Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
CZC24832
i
Other names:
CZC24832, CZC-24832, CZC 24832
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
GSK
Drug class:
PI3Kγ inhibitor
Related drugs:
‹
duvelisib (26)
IPI-549 (6)
RP6530 (6)
BR101801 (1)
CB-006-3 (1)
AZD3458 (0)
ZX-101A (0)
ZX-4081 (0)
duvelisib (26)
IPI-549 (6)
RP6530 (6)
BR101801 (1)
CB-006-3 (1)
AZD3458 (0)
ZX-101A (0)
ZX-4081 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
NSD3 overexpression
Breast Cancer
NSD3 overexpression
Breast Cancer
CZC24832
Sensitive: D – Preclinical
CZC24832
Sensitive
:
D
CZC24832
Sensitive: D – Preclinical
CZC24832
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login